This trial has been completed.

Conditions brain cancer, neck cancer
Treatment 3t mri scan
Phase phase 0
Sponsor University of Michigan
Collaborator National Institutes of Health (NIH)
Start date June 2006
End date June 2016
Trial size 200 participants
Trial identifier NCT00723463, HUM 5527


The purpose of this study is to determine normal measurements (ADC values) from the head and neck of healthy volunteers using 3T MRI.

United States No locations recruiting
Other countries No locations recruiting

Study Design

Intervention model single group assignment
Masking open label
Primary purpose diagnostic
To determine if apparent diffusion coefficient values can differentiate tumors from normal tissues using a 3T MRI scan.
3t mri scan
Establishing/evaluating apparent diffusion coefficient (ADC) values using a 3T MRI scan to differentiate tumors from normal tissue.

Primary Outcomes

To determine if ADC values determined at 3T are different between normal tissues and tumors arising from the extracranial head and neck.
time frame: 1 year

Eligibility Criteria

Male or female participants at least 18 years old.

Inclusion Criteria: - Healthy subjects 18 years of age or older. Exclusion Criteria: - Under 18 years of age - Women of child bearing potential - Pregnant or lactating women - All potential volunteers will be pre-screened by MRI personnel to determine if there is any medical reason that you should not be included in this study.

Additional Information

Official title Retrospective - Prospective - Study to Determine if Apparent Diffusion Coefficient (ADC) Values Can Differentiate Tumors From Normal Tissues at 3T MRI
Principal investigator Ashok Srinivasan, M.D.
Description The purpose of this study is to determine normal measurements (ADC values) from the head and necks of healthy subjects using 3T MRI.
Trial information was received from ClinicalTrials.gov and was last updated in November 2016.
Information provided to ClinicalTrials.gov by University of Michigan.